The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Mechanisms of HBV-related hepatocarcinogenesis
Open accessAbstract
The hepatitis B virus (HBV) is a small enveloped DNA virus, which primarily infects hepatocytes and causes acute and persistent liver disease. Epidemiological studies have provided overwhelming evidence for a causal role of chronic HBV infection in the development of hepatocellular carcinoma, but the molecular mechanisms underlying virally-induced tumourigenesis remain largely debated. In the absence of a dominant oncogene encoded by the HBV genome, indirect roles have been proposed, including insertional activation of cellular cancer-related genes by HBV DNA integration, induction of genetic instability by viral integration or by the regulatory protein HBx, and long-term effects of viral proteins in enhancing immune-mediated liver disease. Recent genetic studies indicate that HBV-related tumours display a distinctive profile with a high rate of chromosomal alterations and low frequency of beta-catenin mutations. This review will discuss the evidence implicating chronic HBV infection as a causal risk factor of primary liver cancer. It will also discuss the molecular mechanisms that are critical for the tumourigenic process due to long lasting infection with HBV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Hepatitis B Virus Infection — Natural History and Clinical Consequences
Ganem, D., & Prince, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031087 · Cited by 2,357
Viral Hepatitis and Liver Disease
Vyas, G. N., Dienstag, J. L., & Hoofnagle, J. H. (1985) · Medical Entomology and Zoology · Cited by 1,860
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708
EASL clinical practice guidelines management of chronic hepatitis B
张学武, & Li, X. (2009) · Inter J Epidemiol Infect Dis · doi:10.3760/cma.j.issn.1673-4149.2009.04.001 · Cited by 1,506
Summers, J., & Mason, W. S. (1982) · Cell · doi:10.1016/0092-8674(82)90157-x · Cited by 1,443
Fattovich, G., Bortolotti, F., & Donato, F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.011 · Cited by 1,348
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.001 · Cited by 1,347
Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305 · cited 1×
“As previously shown for retroviruses [107,108], HBV DNA integration appears to occur frequently in actively transcribed chromosomal regions, within genes or at their immediate vicinity.”
BackgroundTranscriptome classification of HCC is related to gene alterations and to new therapeutic targets
Boyault, S., Rickman, D. S., de Reyniès, A., Balabaud, C., Rebouissou, S., Jeannot, E., Hérault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007) · Hepatology · doi:10.1002/hep.21467 · Cited by 1,258
Hoshida, Y., Nijman, S. M. B., Kobayashi, M., Chan, J. A., Brunet, J.-P., Chiang, D. Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1089 · Cited by 1,238 · cited 1×
“More recently, a meta-analysis integrating transcriptome data from eight independent cohorts has led to the identification of three major molecular subclasses of HCC associated with tumour differentiation and serum alpha-fetoprotein (AFP) levels [78].”
BackgroundHepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Lu, S.-N., Liaw, Y.-F., You, S.-L., Sun, C.-A., Wang, L.-Y., Hsiao, C. K., Chen, P.-J., Chen, D.-S., & Chen, C.-J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,222
Carman, W. F., Hadziyannis, S., Mcgarvey, M. J., Jacyna, M. R., Karayiannis, P., Makris, A., & Thomas, H. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90713-7 · Cited by 1,200
HBx gene of hepatitis B virus induces liver cancer in transgenic mice
Kim, C.-M., Koike, K., Saito, I., Miyamura, T., & Jay, G. (1991) · Nature · doi:10.1038/351317a0 · Cited by 1,158
Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,121
Self-citationHepatocellular carcinoma: Recent trends in the United States
El-Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 972
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Rehermann, B., Ferrari, C., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 854
Novel advancements in the management of hepatocellular carcinoma in 2008
Llovet, J. M., & Bruix, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.022 · Cited by 815
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Villanueva, A., Chiang, D. Y., Newell, P., Peix, J., Thung, S., Alsinet, C., Tovar, V., Roayaie, S., Minguez, B., Sole, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.008 · Cited by 733
EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
Yamashita, T., Forgues, M., Wang, W., Kim, J. W., Ye, Q., Jia, H., Budhu, A., Zanetti, K. A., Chen, Y., Qin, L.-X., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6013 · Cited by 717
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Conner, E. A., Lee, J., Factor, V. M., & Thorgeirsson, S. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.006 · Cited by 710
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
Wang, J., Chenivesse, X., Henglein, B., & Bréchot, C. (1990) · Nature · doi:10.1038/343555a0 · Cited by 671
Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells
Tuttleman, J. S., Pourcel, C., & Summers, J. (1986) · Cell · doi:10.1016/0092-8674(86)90602-1 · Cited by 667
Management of hepatitis B: Summary of a clinical research workshop†
Hoofnagle, J. H., Doo, E., Liang, T. J., Fleischer, R., & Lok, A. S. F. (2007) · Hepatology · doi:10.1002/hep.21627 · Cited by 628
Hussain, S. P., Schwank, J., Staib, F., Wang, X. W., & Harris, C. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210279 · Cited by 621
Brechot, C., Pourcel, C., Louise, A., Rain, B., & Tiollais, P. (1980) · Nature · doi:10.1038/286533a0 · Cited by 612
Yuen, M.-F., Tanaka, Y., Fong, D. Y.-T., Fung, J., Wong, D. K.-H., Yuen, J. C.-H., But, D. Y.-K., Chan, A. O.-O., Wong, B. C.-Y., Mizokami, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.023 · Cited by 584
Laurent–Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac–Sage, P., & Zucman–Rossi, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24798 · Cited by 582
Focus on hepatocellular carcinoma
Bruix, J., Boix, L., Sala, M., & Llovet, J. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00058-3 · Cited by 570
Apc Tumor Suppressor Gene Is the “Zonation-Keeper” of Mouse Liver
Benhamouche, S., Decaens, T., Godard, C., Chambrey, R., Rickman, D. S., Moinard, C., Vasseur-Cognet, M., Kuo, C. J., Kahn, A., Perret, C., et al. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.015 · Cited by 543 · cited 1×
“…immune responses, the viral functions contribute to ceaseless hepatocyte destruction–regeneration, and provide a favorable ground for emergence of genetic and epigenetic alterations leading to hepatocyte transformation. metabolism, which are normally expressed in perivenous hepatocytes [60,61].”
BackgroundKao, J., Chen, P., Lai, M., & Chen, D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50053 · Cited by 536
Viral Hepatitis and Liver Disease
Gupta, S., & Ott, M. (1998) · Principles of Molecular Medicine · doi:10.1007/978-1-59259-726-0_43 · Cited by 518
Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus
Mason, W. S., Seal, G., & Summers, J. W. (1980) · Journal of Virology · doi:10.1128/jvi.36.3.829-836.1980 · Cited by 514
The Enigmatic X Gene of Hepatitis B Virus
Bouchard, M. J., & Schneider, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12725-12734.2004 · Cited by 498
Beck, J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i1.48 · Cited by 494
Pollicino, T., Belloni, L., Raffa, G., Pediconi, N., Squadrito, G., Raimondo, G., & Levrero, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.001 · Cited by 472
Woodchuck hepatitis virus X protein is required for viral infection in vivo
Zoulim, F., Saputelli, J., & Seeger, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.2026-2030.1994 · Cited by 453
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection
Pollicino, T., Squadrito, G., Cerenzia, G., Cacciola, I., Raffa, G., Craxı̀, A., Farinati, F., Missale, G., Smedile, A., Tiribelli, C., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.048 · Cited by 427
The global impact of vaccination against hepatitis B: A historical overview
Zanetti, A. R., Van Damme, P., & Shouval, D. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.056 · Cited by 420
Dejean, A., Bougueleret, L., Grzeschik, K.-H., & Tiollais, P. (1986) · Nature · doi:10.1038/322070a0 · Cited by 407
Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease
Sumi, H., Yokosuka, O., Seki, N., Arai, M., Imazeki, F., Kurihara, T., Kanda, T., Fukai, K., Kato, M., & Saisho, H. (2003) · Hepatology · doi:10.1053/jhep.2003.50036 · Cited by 403
Dysregulation of growth factor signaling in human hepatocellular carcinoma
Breuhahn, K., Longerich, T., & Schirmacher, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209556 · Cited by 391
Liu, S., Zhang, H., Gu, C., Yin, J., He, Y., Xie, J., & Cao, G. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp180 · Cited by 388
New therapies for hepatocellular carcinoma
Avila, M. A., Berasain, C., Sangro, B., & Prieto, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209550 · Cited by 383
High-throughput retroviral tagging to identify components of specific signaling pathways in cancer
Mikkers, H., Allen, J., Knipscheer, P., Romeyn, L., Hart, A., Vink, E., & Berns, A. (2002) · Nature Genetics · doi:10.1038/ng950 · Cited by 377
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks
Chen, H. S., Kaneko, S., Girones, R., Anderson, R. W., Hornbuckle, W. E., Tennant, B. C., Cote, P. J., Gerin, J. L., Purcell, R. H., & Miller, R. H. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1218-1226.1993 · Cited by 370
Paterlini-Bréchot, P., Saigo, K., Murakami, Y., Chami, M., Gozuacik, D., Mugnier, C., Lagorce, D., & Bréchot, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206492 · Cited by 354
Liaw, Y.-F., Chu, C.-M., Su, I.-J., Huang, M.-J., Lin, D.-Y., & Chang-Chien, C.-S. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80114-0 · Cited by 341
Murakami, Y., Saigo, K., Takashima, H., Minami, M., Okanoue, T., Bréchot, C., & Paterlini-Bréchot, P. (2005) · Gut · doi:10.1136/gut.2004.054452 · Cited by 331
Genetics of hepatocellular carcinoma
Annick Buendia, M. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0319 · Cited by 329
Genetics of hepatocellular tumors
Laurent-Puig, P., & Zucman-Rossi, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209547 · Cited by 317
The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice
Terradillos, O., Billet, O., Renard, C.-A., Levy, R., Molina, T., Briand, P., & Buendia, M. A. (1997) · Oncogene · doi:10.1038/sj.onc.1200850 · Cited by 285
Self-citationde Thé, H., Marchio, A., Tiollais, P., & Dejean, A. (1987) · Nature · doi:10.1038/330667a0 · Cited by 284
Molecular functions and biological roles of hepatitis B virus x protein
Tang, H., Oishi, N., Kaneko, S., & Murakami, S. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00299.x · Cited by 282
Nuclear import of hepatitis B virus capsids and release of the viral genome
Rabe, B., Vlachou, A., Panté, N., Helenius, A., & Kann, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1730940100 · Cited by 280
Bréchot, C., Gozuacik, D., Murakami, Y., & Paterlini-Bréchot, P. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0321 · Cited by 276
Zucman-Rossi, J., Benhamouche, S., Godard, C., Boyault, S., Grimber, G., Balabaud, C., Cunha, A. S., Bioulac-Sage, P., & Perret, C. (2007) · Oncogene · doi:10.1038/sj.onc.1209824 · Cited by 256
Staib, F., Perwez Hussain, S., Hofseth, L. J., Wang, X. W., & Harris, C. C. (2003) · Human Mutation · doi:10.1002/humu.10176 · Cited by 241
Ferber, M. J., Montoya, D. P., Yu, C., Aderca, I., McGee, A., Thorland, E. C., Nagorney, D. M., Gostout, B. S., Burgart, L. J., Boix, L., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206528 · Cited by 238
Sun, C.-A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg041 · Cited by 234
Ming, L., Thorgeirsson, S. S., Gail, M. H., Lu, P., Harris, C. C., Wang, N., Shao, Y., Wu, Z., Liu, G., Wang, X., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.36366 · Cited by 233
Newell, P., Toffanin, S., Villanueva, A., Chiang, D. Y., Minguez, B., Cabellos, L., Savic, R., Hoshida, Y., Lim, K. H., Melgar-Lesmes, P., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.028 · Cited by 222
Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas
Su, Q., Schröder, C. H., Hofmann, W. J., Otto, G., Pichlmayr, R., & Bannasch, P. (1998) · Hepatology · doi:10.1002/hep.510270428 · Cited by 219
Ni, Y.-H., Chang, M.-H., Wang, K.-J., Hsu, H.-Y., Chen, H.-L., Kao, J.-H., Yeh, S.-H., Jeng, Y.-M., Tsai, K.-S., & Chen, D.-S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.048 · Cited by 213
Hepatitis B virus X‐gene product: A promiscuous transcriptional activator
Rossner, M. T. (1992) · Journal of Medical Virology · doi:10.1002/jmv.1890360207 · Cited by 211
Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell
Bock, C.-T., Schranz, P., Schröder, C. H., & Zentgraf, H. (1994) · Virus Genes · doi:10.1007/bf01703079 · Cited by 209
Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)86002-x · Cited by 205
Cougot, D., Wu, Y., Cairo, S., Caramel, J., Renard, C.-A., Lévy, L., Buendia, M. A., & Neuveut, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606774200 · Cited by 203
Self-citationSlagle, B. L., Lee, T.-H., Medina, D. J., Finegold, M. J., & Butel, J. S. (1996) · Molecular Carcinogenesis · Cited by 181
Enhancement of Hepatitis B Virus Replication by the Regulatory X Protein In Vitro and In Vivo
Keasler, V. V., Hodgson, A. J., Madden, C. R., & Slagle, B. L. (2007) · Journal of Virology · doi:10.1128/jvi.02020-06 · Cited by 176
Leupin, O., Bontron, S., Schaeffer, C., & Strubin, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.4238-4245.2005 · Cited by 167
Specific mutations of hepatitis B virus in plasma predict liver cancer development
Kuang, S.-Y., Jackson, P. E., Wang, J.-B., Lu, P.-X., Muñoz, A., Qian, G.-S., Kensler, T. W., & Groopman, J. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308232100 · Cited by 165
Hepadnaviral X protein: Review of recent progress
Benedict Yen, T. S. (1996) · Journal of Biomedical Science · doi:10.1007/bf02253575 · Cited by 163
In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA
Soussan, P., Garreau, F., Zylberberg, H., Ferray, C., Brechot, C., & Kremsdorf, D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8098 · Cited by 163
Cholestasis is a marker for hepatocellular carcinomas displaying β‐catenin mutations
Audard, V, Grimber, G., Elie, C., Radenen, B., Audebourg, A., Letourneur, F., Soubrane, O., Vacher‐Lavenu, M., Perret, C., Cavard, C., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2169 · Cited by 162
Legoix, P., Bluteau, O., Bayer, J., Perret, C., Balabaud, C., Belghiti, J., Franco, D., Thomas, G., Laurent-Puig, P., & Zucman-Rossi, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202800 · Cited by 162
Zonal gene expression in murine liver: Lessons from tumors
Hailfinger, S., Jaworski, M., Braeuning, A., Buchmann, A., & Schwarz, M. (2006) · Hepatology · doi:10.1002/hep.21082 · Cited by 161
Differential gene expression between chronic hepatitis B and C hepatic lesion
Honda, M., Kaneko, S., Kawai, H., Shirota, Y., & Kobayashi, K. (2001) · Gastroenterology · doi:10.1053/gast.2001.22468 · Cited by 161
A Pivotal Role of Cyclic AMP-Responsive Element Binding Protein in Tumor Progression
Abramovitch, R., Tavor, E., Jacob-Hirsch, J., Zeira, E., Amariglio, N., Pappo, O., Rechavi, G., Galun, E., & Honigman, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2089 · Cited by 158
Woo, H. G., Park, E. S., Cheon, J. H., Kim, J. H., Lee, J., Park, B. J., Kim, W. K., Park, S. C., Chung, Y. J., Kim, B. G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1473 · Cited by 157
Fransvea, E., Mazzocca, A., Antonaci, S., & Giannelli, G. (2008) · Hepatology · doi:10.1002/hep.22731 · Cited by 140
Breiner, K. M., Schaller, H., & Knolle, P. (2001) · Hepatology · doi:10.1053/jhep.2001.27810 · Cited by 134
Wang, J., Zindy, F., Chenivesse, X., Lamas, E., Henglein, B., & Bréchot, C. (1992) · PubMed · Cited by 127
Comparative and integrative functional genomics of HCC
Lee, J.-S., & Thorgeirsson, S. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209561 · Cited by 121
Madden, C. R., Finegold, M. J., & Slagle, B. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.8.3851-3858.2001 · Cited by 120
Yaginuma, K., Kobayashi, H., Kobayashi, M., Morishima, T., Matsuyama, K., & Koike, K. (1987) · Journal of Virology · doi:10.1128/jvi.61.6.1808-1813.1987 · Cited by 119
Wu, B.-K., Li, C.-C., Chen, H.-J., Chang, J.-L., Jeng, K.-S., Chou, C., Hsu, M., & Tsai, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.089 · Cited by 118
Hsieh, Y., Wu, T.-T., Huang, C., Hsieh, Y., Hwang, J.-M., & Liu, J.-Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2486 · Cited by 115
Yaginuma, K., Kobayashi, M., Yoshida, E., & Koike, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4458 · Cited by 110
Wnt/β-Catenin Pathway in Hepatocellular Carcinoma Pathogenesis and Liver Physiology
Cavard, C., Colnot, S., Audard, V., Benhamouche, S., Finzi, L., Torre, C., Grimber, G., Godard, C., Terris, B., & Perret, C. (2008) · Future Oncology · doi:10.2217/14796694.4.5.647 · Cited by 102
Molecularly targeted therapy for hepatocellular carcinoma
Tanaka, S., & Arii, S. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.01006.x · Cited by 97
cis-Activation of the Human Telomerase Gene (hTERT) by the Hepatitis B Virus Genome
Horikawa, I., & Barrett, J. C. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.15.1171 · Cited by 96
In vitro tumorigenicity of hepatitis B virus DNA and HBx protein
Seifer, M., Höhne, M. W., Schaefer, S., & Gerlich, W. H. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90026-8 · Cited by 95
Ikeda, K., Kobayashi, M., Someya, T., Saitoh, S., Hosaka, T., Akuta, N., Suzuki, F., Suzuki, Y., Arase, Y., & Kumada, H. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01085.x · Cited by 89
Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA.
Hino, O., Tabata, S., & Hotta, Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9248 · Cited by 88
Biology of transforming growth factor ? in hepatocarcinogenesis
Rossmanith, W., & Schulte‐Hermann, R. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4<430::aid-jemt1028>3.0.co;2-3 · Cited by 86
Schuster, R., Gerlich, W. H., & Schaefer, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203417 · Cited by 86
Honda, M., Yamashita, T., Ueda, T., Takatori, H., Nishino, R., & Kaneko, S. (2006) · Hepatology · doi:10.1002/hep.21383 · Cited by 82
Barnabas, S., Hai, T., & ANDRISANI, O. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20684 · Cited by 81
Wen, Y., Golubkov, V. S., Strongin, A. Y., Jiang, W. B., & Reed, J. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708419200 · Cited by 78
Kim, Y. C., Song, K.-S., Yoon, G., Nam, M., & Ryu, W. (2001) · Oncogene · doi:10.1038/sj.onc.1203840 · Cited by 77
Madden, C. R., Finegold, M. J., & Slagle, B. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11770-11774.2002 · Cited by 73
Tralhão, J. G., Roudier, J., Morosan, S., Giannini, C., Tu, H., Goulenok, C., Carnot, F., Zavala, F., Joulin, V., Kremsdorf, D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092657699 · Cited by 72
Modulation of TGF-beta signaling during progression of chronic liver diseases
Matsuzaki, K. (2009) · Frontiers in bioscience · doi:10.2741/3423 · Cited by 70
HBV X protein targets hBubR1, which induces dysregulation of the mitotic checkpoint
Kim, S., Park, S. Y., Yong, H., Famulski, J. K., Chae, S., Lee, J.-H., Kang, C.-M., Saya, H., Chan, G. K. T., & Cho, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210998 · Cited by 65
Lee, C., Hsieh, K., & Ko, Y. (2003) · PubMed · Cited by 65
Pineau, P., Marchio, A., Nagamori, S., Seki, S., Tiollais, P., & Dejean, A. (2003) · Hepatology · doi:10.1053/jhep.2003.50138 · Cited by 61
Rakotomalala, L., Studach, L. L., Wang, W., Grégori, G., Hullinger, R. L., & ANDRISANI, O. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802751200 · Cited by 56
JNK1, a potential therapeutic target for hepatocellular carcinoma
Chen, F., Beezhold, K., & Castranova, V. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.06.005 · Cited by 52
Berasain, C., Patil, D., Perara, E., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201893 · Cited by 49
Garcia, M., de Thé, H., Tiollais, P., Samarut, J., & Dejean, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.89 · Cited by 48
Large cell change of hepatocytes in chronic viral hepatitis represents a senescent-related lesion
Ikeda, H., Sasaki, M., Sato, Y., Harada, K., Zen, Y., Mitsui, T., & Nakanuma, Y. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.06.009 · Cited by 44
Hodgson, A. J., Keasler, V. V., & Slagle, B. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2695 · Cited by 42
Hepatitis B virus X protein overcomes oncogenic RAS‐induced senescence in human immortalized cells
Oishi, N., Shilagardi, K., Nakamoto, Y., Honda, M., Kaneko, S., & Murakami, S. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00579.x · Cited by 37
MOLECULAR BIOLOGY OF HEPATITIS B VIRUS
Yu, W., & Tiollais, P. (1999) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70065-9 · Cited by 37
Tsuei, D., Chang, M., Chen, P., Hsu, T.-Y., & Ni, Y. (2002) · Journal of Medical Virology · doi:10.1002/jmv.10240 · Cited by 27
Carcinogenesis Induced by Hepatitis B Virus
Cougot, D., Buendia, M., & Neuveut, C. (2008) · Translational research in biomedicine · doi:10.1159/000141035 · Cited by 5
Self-citation
Cited by
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Cancer immunoediting and resistance to T cell-based immunotherapy
O’Donnell, J. S., Teng, M. W. L., & Smyth, M. J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0142-8 · Cited by 1,759
Genetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N. P., Lee, W. H., Ariyaratne, P. N., Tennakoon, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2295 · Cited by 991
Advances in molecular classification and precision oncology in hepatocellular carcinoma
Rebouissou, S., & Nault, J.-C. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.017 · Cited by 575
Metadata
- Authors
- Neuveut, C., Wei, Y., & Buendia, M. A.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 52
- Issue
- 4
- Pages
- 594-604
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2057211093
- Cited by
- 421
- References
- 121
- FWCI
- 19.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.